The Tx for co-infection raises a question at least for me.
PBMs such as CVS when they sign exclusive deal with Gilead for Harvoni that's contra indicated for co-infection, how are they going to prescribe Viekira Pak from ABBV/ENTA ? Or did I misunderstood the CVS/GIlead deal. Thanks as always
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.